349 related articles for article (PubMed ID: 29239349)
21. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
22. Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exercise.
Mirna M; Lichtenauer M; Wernly B; Paar V; Jung C; Kretzschmar D; Uhlemann M; Franz M; Hoppe UC; Schulze PC; Hilberg T; Adams V; Sponder M; Möbius-Winkler S
Panminerva Med; 2020 Sep; 62(3):135-142. PubMed ID: 32309918
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes.
Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A
Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985
[No Abstract] [Full Text] [Related]
24. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
26. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
27. [Changes of heart-type fatty acid-binding protein in children with chronic heart failure and its significance].
Sun YP; Wang WD; Ma SC; Wang LY; Qiao LY; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):99-101. PubMed ID: 23428121
[TBL] [Abstract][Full Text] [Related]
28. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
[TBL] [Abstract][Full Text] [Related]
30. Circulating H-FABP as a biomarker of frailty in patients with chronic heart failure.
Ahmad F; Karim A; Khan J; Qaisar R
Exp Biol Med (Maywood); 2023 Aug; 248(16):1383-1392. PubMed ID: 37787063
[TBL] [Abstract][Full Text] [Related]
31. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure.
Setsuta K; Seino Y; Kitahara Y; Arau M; Ohbayashi T; Takano T; Mizuno K
Circ J; 2008 Apr; 72(4):569-74. PubMed ID: 18362427
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade.
Lichtenauer M; Goebel B; Paar V; Wernly B; Gecks T; Rohm I; Förster M; Betge S; Figulla HR; Hoppe UC; Kelm M; Franz M; Jung C
Clin Hemorheol Microcirc; 2017; 67(1):101-113. PubMed ID: 28550241
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
[No Abstract] [Full Text] [Related]
35. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
36. Growth-differentiation factor-15 and major cardiac events.
Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
[TBL] [Abstract][Full Text] [Related]
37. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
[TBL] [Abstract][Full Text] [Related]
38. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
39. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
Perry CM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
[TBL] [Abstract][Full Text] [Related]
40. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
